Table1:
Participant characteristics
| HC (n = 22) Mean ± SD | FM negative (n = 24) Mean ± SD | FM positive (n = 22) Mean ± SD | P value (t test)! | P value (ANOVA) | |
|---|---|---|---|---|---|
| Age (years) | 41.15 ± 8.830 | 42.38 ± 12.37 | 43.95 ± 14.00 | 0.687 | 0.788 |
| Gender (% Female) | 68% | 63% | 77% | 0.277 | 0.552 |
| BMI | 28.35 ± 8.10 | 28.76 ± 6.20 | 31.34 ± 6.13 | 0.163 | 0.296 |
| Race | 0.576 | 0.316 | |||
| White | 68.00% | 66.70% | 72.70% | ||
| Black | 5% | 16.70% | 13.70% | ||
| Asian | 18.00% | 4.20% | 0.00% | ||
| More than one race | 9.00% | 0.00% | 4.55% | ||
| Other | 0.00% | 0.00% | 4.55% | ||
| Pain average (NRS) | ----------- | 4.13 ± 1.12 | 5.27 ± 1.49 | < 0.01* | |
| Pain duration (months) | ----------- | 75.04 ± 104.87 | 135.09 ± 171.12 | 0.155 | |
| number of pain locations | ----------- | 4.50 ± 1.79 | 9.77 ± 3.84 | < 0.001* | |
| Opioid use (%Yes) | ----------- | 0% | 36% | < 0.001* |
FM: Fibromyalgia
HC: Healthy controls
BMI: Body mass index, NRS: Numeric rating scale
Comparisons of FM negative CLBP participants and FM negative CLBP participants